Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.6950
+0.0362 (5.49%)
Aug 29, 2025, 4:00 PM EDT

Elite Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2021
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2017 - 2021
735465157293562
Upgrade
Market Cap Growth
267.87%195.83%434.24%-16.81%-42.59%1.75%
Upgrade
Enterprise Value
720468159273161
Upgrade
Last Close Price
0.690.430.150.030.030.06
Upgrade
PE Ratio
--7.818.263.9712.10
Upgrade
PS Ratio
6.975.532.770.861.102.42
Upgrade
PB Ratio
15.418.682.731.011.403.81
Upgrade
P/TBV Ratio
15.508.732.741.031.433.92
Upgrade
P/FCF Ratio
40.7679.70--5.8821.50
Upgrade
P/OCF Ratio
38.4962.33-8.815.4319.27
Upgrade
EV/Sales Ratio
6.825.562.810.800.962.40
Upgrade
EV/EBITDA Ratio
17.4020.4313.095.254.9417.86
Upgrade
EV/EBIT Ratio
18.4322.0514.756.926.1128.90
Upgrade
EV/FCF Ratio
39.9380.19--5.1521.24
Upgrade
Debt / Equity Ratio
0.140.200.200.130.110.15
Upgrade
Debt / EBITDA Ratio
0.160.460.950.730.430.66
Upgrade
Debt / FCF Ratio
0.371.87--0.460.83
Upgrade
Asset Turnover
1.060.930.910.901.050.99
Upgrade
Inventory Turnover
2.813.012.692.162.972.95
Upgrade
Quick Ratio
5.393.422.041.401.731.15
Upgrade
Current Ratio
7.234.883.072.752.822.10
Upgrade
Return on Equity (ROE)
-20.42%-7.77%46.47%13.15%43.01%37.96%
Upgrade
Return on Assets (ROA)
24.50%14.72%10.83%6.52%10.33%5.14%
Upgrade
Return on Capital (ROIC)
39.27%19.82%13.20%8.15%13.62%7.92%
Upgrade
Return on Capital Employed (ROCE)
38.80%25.10%15.30%12.00%17.80%10.30%
Upgrade
Earnings Yield
-1.47%-0.93%12.80%12.11%25.18%8.27%
Upgrade
FCF Yield
2.45%1.26%-2.57%-8.15%17.00%4.65%
Upgrade
Buyback Yield / Dilution
-2.86%-4.40%-1.02%-0.23%-7.17%5.06%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.